Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · USD
$1.45
-0.07 (-4.6%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first AUTL analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 385.9M | |
|---|---|---|
| Revenue (ttm) | 92.6M | |
| Net income (ttm) | -289M | |
| EPS (ttm) | -$1.09 | |
| Shares out | 266.1M | |
| Volume | 716,974 | |
| Beta | 2.03 | |
| Price target | $8.55 | +489.7% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 92.6M
- Net income (ttm)
- -289M
- EPS (ttm)
- -$1.09
- Market cap
- 385.9M
Fair-value bridge
- Current price
- $1.45
Analyst consensus
Recommendation
Strong Buy
Price target
$8.55
+489.7%
In the news
Latest news · AUTL
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 385.9M
- P/S
- 4.2x
- P/B
- 3.5x
Profitability
- Gross margin
- -125.1%
- Operating margin
- -285.5%
- ROE
- -120.4%
- ROA
- -26.0%
- ROIC
- -28.5%
Balance sheet
- Debt / equity
- 3.39
- Current ratio
- 5.80
- Quick ratio
- 4.96
Trading
- Beta
- 2.03
- Volume
- 716,974
- Dividend yield
- 0.0%